| Erythropoietin and its angiogenic activity P Kimáková, P Solár, Z Solárová, R Komel, N Debeljak International journal of molecular sciences 18 (7), 1519, 2017 | 137 | 2017 |
| Erythropoietin and cancer: the unintended consequences of anemia correction N Debeljak, P Solár, AJ Sytkowski Frontiers in immunology 5, 563, 2014 | 137 | 2014 |
| Many facets of mammalian lanosterol 14α-demethylase from the evolutionarily conserved cytochrome P450 family CYP51 N Debeljak, M Fink, D Rozman Archives of biochemistry and biophysics 409 (1), 159-171, 2003 | 128 | 2003 |
| Mouse knockout of the cholesterogenic cytochrome P450 lanosterol 14α-demethylase (Cyp51) resembles Antley-Bixler syndrome H Motaln, KD Wagner, N Debeljak, M Rassoulzadegan, J Ačimovič, ... Journal of Biological Chemistry 286 (33), 29086-29097, 2011 | 112 | 2011 |
| The role of PI3K/AKT and MAPK signaling pathways in erythropoietin signalization Z Tóthová, M Šemeláková, Z Solárová, J Tomc, N Debeljak, P Solár International Journal of Molecular Sciences 22 (14), 7682, 2021 | 81 | 2021 |
| Variability in the immunodetection of His-tagged recombinant proteins N Debeljak, L Feldman, KL Davis, R Komel, AJ Sytkowski Analytical biochemistry 359 (2), 216-223, 2006 | 78 | 2006 |
| Expression of estrogen and progesterone receptors and estrogen metabolizing enzymes in different breast cancer cell lines N Hevir, N Trošt, N Debeljak, TL Rižner Chemico-biological interactions 191 (1-3), 206-216, 2011 | 75 | 2011 |
| New aspects on lanosterol 14α-demethylase and cytochrome P450 evolution: lanosterol/cycloartenol diversification and lateral transfer T Režen, N Debeljak, D Kordiš, D Rozman Journal of molecular evolution 59, 51-58, 2004 | 63 | 2004 |
| Tissue-specific transcriptional regulation of the cholesterol biosynthetic pathway leads to accumulation of testis meiosis-activating sterol (T-MAS) KF Tacer, TB Haugen, M Baltsen, N Debeljak, D Rozman Journal of lipid research 43 (1), 82-89, 2002 | 50 | 2002 |
| Cannabinoids and hormone receptor-positive breast cancer treatment L Dobovišek, F Krstanović, S Borštnar, N Debeljak Cancers 12 (3), 525, 2020 | 48 | 2020 |
| Characterization of the mouse lanosterol 14α-demethylase (CYP51), a new member of the evolutionarily most conserved cytochrome P450 family N Debeljak, S Horvat, K Vouk, M Lee, D Rozman Archives of biochemistry and biophysics 379 (1), 37-45, 2000 | 46 | 2000 |
| Erythropoietin and erythropoiesis stimulating agents N Debeljak, AJ Sytkowski Drug testing and analysis 4 (11), 805-812, 2012 | 40 | 2012 |
| Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis D Vočanec, T Prijatelj, N Debeljak, T Kunej International journal of laboratory hematology 41 (2), 162-167, 2019 | 38 | 2019 |
| STAT5 as a key protein of erythropoietin signalization Z Tóthová, J Tomc, N Debeljak, P Solár International journal of molecular sciences 22 (13), 7109, 2021 | 37 | 2021 |
| Network and systems medicine: position paper of the European collaboration on science and technology action on open multiscale systems medicine B Comte, J Baumbach, A Benis, J Basílio, N Debeljak, Å Flobak, ... Network and systems medicine 3 (1), 67-90, 2020 | 31 | 2020 |
| Erythropoietin: new approaches to improved molecular designs and therapeutic alternatives N Debeljak, AJ Sytkowski Current pharmaceutical design 14 (13), 1302-1310, 2008 | 29 | 2008 |
| Erythrocytosis: genes and pathways involved in disease development J Gašperšič, A Kristan, T Kunej, IP Zupan, N Debeljak Blood Transfusion 19 (6), 518, 2020 | 26 | 2020 |
| Molecular insights into the oxygen-sensing pathway and erythropoietin expression regulation in erythropoiesis J Tomc, N Debeljak International journal of molecular sciences 22 (13), 7074, 2021 | 24 | 2021 |
| Combinations of genetic changes in the human cAMP-responsive element modulator gene: a clue towards understanding some forms of male infertility? K Vouk, P Hudler, L Strmšnik, M Fink, G Majdič, B Zorn, E Lalli, ... Molecular human reproduction 11 (8), 567-574, 2005 | 24 | 2005 |
| Correlation between erythropoietin receptor (s) and estrogen and progesterone receptor expression in different breast cancer cell lines N Trošt, N Hevir, TL Rižner, N Debeljak International journal of molecular medicine 31 (3), 717-725, 2013 | 23 | 2013 |
Damjana RozmanUniversity of LjubljanaZweryfikowany adres z mf.uni-lj.si
